Qingjun Liu

2.1k total citations
80 papers, 1.3k citations indexed

About

Qingjun Liu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Qingjun Liu has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 16 papers in Epidemiology and 15 papers in Cancer Research. Recurrent topics in Qingjun Liu's work include Heme Oxygenase-1 and Carbon Monoxide (7 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Acute Ischemic Stroke Management (5 papers). Qingjun Liu is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (7 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Acute Ischemic Stroke Management (5 papers). Qingjun Liu collaborates with scholars based in China, Canada and United States. Qingjun Liu's co-authors include Zhongjie Sun, Ligong Chen, Qi Li, Wen‐Song Yang, Xing-Chen Wang, Hong Zhou, Peng Xie, Gan Chen, Dan Zhu and Xin Xiong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Qingjun Liu

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingjun Liu China 18 451 293 250 248 231 80 1.3k
Ming Xu China 28 740 1.6× 286 1.0× 185 0.7× 288 1.2× 244 1.1× 119 2.2k
Xin He China 19 368 0.8× 135 0.5× 80 0.3× 161 0.6× 176 0.8× 115 1.2k
Giusy Elia Italy 26 528 1.2× 231 0.8× 101 0.4× 508 2.0× 186 0.8× 77 2.5k
Weili Yang China 24 898 2.0× 187 0.6× 88 0.4× 226 0.9× 422 1.8× 110 2.1k
Pingli Wang China 16 363 0.8× 106 0.4× 72 0.3× 285 1.1× 211 0.9× 63 1.1k
Hong Chen China 30 1.3k 2.9× 321 1.1× 338 1.4× 219 0.9× 544 2.4× 118 2.9k
Jiaxing Sun China 23 427 0.9× 162 0.6× 103 0.4× 172 0.7× 170 0.7× 92 1.4k
Anna Severino Italy 23 679 1.5× 275 0.9× 93 0.4× 128 0.5× 97 0.4× 58 1.5k
Ni Zhang China 18 374 0.8× 106 0.4× 80 0.3× 215 0.9× 188 0.8× 64 1.0k

Countries citing papers authored by Qingjun Liu

Since Specialization
Citations

This map shows the geographic impact of Qingjun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjun Liu more than expected).

Fields of papers citing papers by Qingjun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingjun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjun Liu. The network helps show where Qingjun Liu may publish in the future.

Co-authorship network of co-authors of Qingjun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingjun Liu. A scholar is included among the top collaborators of Qingjun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingjun Liu. Qingjun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Liu, Qingjun, Qi Li, Yang Zhao, et al.. (2020). Prognostic value of cerebral infarction coefficient in patients with massive cerebral infarction. Clinical Neurology and Neurosurgery. 196. 106009–106009. 8 indexed citations
5.
Zhang, Lingyan, Qingjun Liu, Li Huang, et al.. (2020). Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway. Biochemical and Biophysical Research Communications. 531(3). 364–371. 17 indexed citations
6.
Shao, Gaohai, Qingjun Liu, Ling Yang, et al.. (2020). Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan. Journal of Inflammation. 17(1). 10–10. 1 indexed citations
7.
Liu, Changnian, Bin Liu, Chunping Xu, et al.. (2019). ETH-155008, a Novel Selective Dual Inhibitor of FLT3 and CDK4/6 in Preclinical Treatment of Acute Myeloid Leukemia. Blood. 134(Supplement_1). 5141–5141. 4 indexed citations
8.
Yang, Wen‐Song, Qi Li, Rui Li, et al.. (2017). Defining the Optimal Midline Shift Threshold to Predict Poor Outcome in Patients with Supratentorial Spontaneous Intracerebral Hemorrhage. Neurocritical Care. 28(3). 314–321. 33 indexed citations
9.
Shen, Hongliang, et al.. (2017). The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis. Clinical and investigative medicine. 40(2). E40–E48. 8 indexed citations
10.
Liu, Qingjun, Shihui Zhang, Gan Chen, & Hong Zhou. (2017). E3 ubiquitin ligase Nedd4 inhibits AP-1 activity and TNF-α production through targeting p38α for polyubiquitination and subsequent degradation. Scientific Reports. 7(1). 4521–4521. 12 indexed citations
11.
Lin, Bin, et al.. (2015). Management of combined atlas-axis fractures: a review of forty one cases. International Orthopaedics. 40(6). 1179–1186. 6 indexed citations
12.
Jia, Xiaowei, Qingjun Liu, Yanshu Zhang, et al.. (2014). Myelin protein zero and its antibody in serum as biomarkers of n -hexane-induced peripheral neuropathy and neurotoxicity effects. Chinese Medical Journal. 127(8). 1536–1540. 6 indexed citations
13.
Liu, Qingjun, Hong Zhou, Wallace Y. Langdon, & Jian Zhang. (2014). E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Cell Cycle. 13(12). 1875–1884. 55 indexed citations
14.
Guo, Ying, Chunbao Zang, Yajun Li, et al.. (2013). Association Between TGF-β1 Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 17(11). 814–820. 13 indexed citations
15.
Liu, Qingjun, et al.. (2012). The Activity of SV40 Promoter Can Be Inhibited by Overexpression of Heme Oxygenase-1 in Tumor Cells. Cell Biochemistry and Biophysics. 65(3). 287–295. 3 indexed citations
16.
Han, Huamin, et al.. (2011). An Efficient Vector System to Modify Cells Genetically. PLoS ONE. 6(11). e26380–e26380. 6 indexed citations
17.
Yao, Xing, Jiarong Zhang, Huarong Huang, et al.. (2010). Histone deacetylase inhibitor promotes differentiation of embryonic stem cells into neural cells in adherent monoculture. Chinese Medical Journal. 123(6). 734–738. 12 indexed citations
18.
Dai, Yufei, Laiyu Li, Yong Niu, et al.. (2009). Effects of Genetic Polymorphisms of N-Acetyltransferase on Trichloroethylene-Induced Hypersensitivity Dermatitis among Exposed Workers. Industrial Health. 47(5). 479–486. 13 indexed citations
19.
Duan, Huawei, Shuguang Leng, Yufei Dai, et al.. (2009). Biomarkers measured by cytokinesis-block micronucleus cytome assay for evaluating genetic damages induced by polycyclic aromatic hydrocarbons. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 677(1-2). 93–99. 63 indexed citations
20.
Liu, Yongchang, et al.. (2002). Detection of serum DNA in cancer patients by modified methylation specific PCR. The Chinese-German Journal of Clinical Oncology. 1(3). 170–171. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Xu Breakdown of academic impact, for papers by Xin He Breakdown of academic impact, for papers by Giusy Elia Breakdown of academic impact, for papers by Weili Yang Breakdown of academic impact, for papers by Pingli Wang Breakdown of academic impact, for papers by Hong Chen Breakdown of academic impact, for papers by Jiaxing Sun Breakdown of academic impact, for papers by Anna Severino Breakdown of academic impact, for papers by Ni Zhang
Rankless by CCL
2026